Stock Taper
SCREENER COMPARE ANY 2 STOCKS
PCRX
PACIRA BIOSCIENCES, INC.
NASDAQ
$26.35
▼ DOWN 0.94% (-0.25)

KEY STATISTICS

Market Cap$1.04 B
52w High$27.66
52w Low$18.80
Dividend Yield—
Frequency—
P/E10.13
Volume447.34K
Shares Out.39.34M

COMPANY

LEADERSHIP

Frank D. Lee
CHIEF EXECUTIVE
Frank D. Lee

COMPENSATION 2026

Salary$634,038
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$91,152
Total$727,378

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 3, 2011
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
827

PRICE TARGET

Target High$32.00
Target Low$25.00
Target Median$30.00
Target Consensus$29.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$181.76M
NOV
5
THU

PRICE

$26.35 ▼ DOWN 0.94% (−$0.25)
$26.32$26.40$26.47$26.559:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM26.35

About Pacira BioSciences, Inc.

https://www.pacira.com ↗

Pacira BioSciences, Inc. develops non-opioid pain management and regenerative health solutions, including EXPAREL, ZILRETTA, and iovera, utilizing innovative drug delivery technologies for healthcare providers in the U.S.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT PACIRA BIOSCIENCES, INC. IS KNOWN FOR

EXPAREL
EXPAREL

EXPAREL is a long-acting, non-opioid local anesthetic used during surgery to provide postsurgical pain relief and reduce opioid dependence, serving as Pacira's flagship product and key revenue driver.

COMPETITORS

COMPETITOR
AS ASRT COMPARE
BHC COMPARE
COLL COMPARE
HRTX COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$178.04M $196.87M ▲$177.38M ▼$190.49M ▲
EXPAREL$139.9M $155.78M ▲$143.27M ▼$147.82M ▲
ZILRETTA$28.98M $32.98M ▲$26.77M ▼$32.65M ▲
Bupivacaine Liposome Injectable Suspension$2.69M $1.11M ▼$1.16M ▲$3.22M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
208
LISTED HERE
26
RANKED BY POSITION SIZE
AFTY
1.20% · 4.9M
IJR
0.05% · 2.4M
VTS.AX
0.00% · 1.2M
AVUV
0.06% · 699.3K
XPH
1.70% · 398.9K
FESM
0.12% · 284.4K
DFSV
0.07% · 235.0K
BSVO
0.22% · 203.5K
FNDA
0.06% · 190.5K
SFLO
0.44% · 141.9K
PRFZ
0.09% · 91.5K
PINK
0.61% · 87.4K
PSC
0.08% · 83.9K
SIXS
1.22% · 66.3K
GSSC
0.16% · 64.2K
EES
0.16% · 43.3K
JPSE
0.18% · 39.6K
XRSU.L
0.03% · 34.3K
DSMC
0.50% · 27.5K
ISMD
0.21% · 27.0K
RSSL
0.03% · 19.0K
PILL
1.14% · 10.0K
TILT
0.01% · 7.9K
PL
PLCY
1.81% · 7.6K
SAGP
0.21% · 6.7K
SQLV
0.44% · 6.7K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
97.85%
HOLDERS
412
TOP 12 OF 412 · RANKED BY POSITION SIZE
Blackrock Inc.
8.0M sh · $229.08M
Blackrock, Inc.
7.3M sh · $189.05M
Vanguard Group Inc
5.2M sh · $133.94M
Doma Perpetual Capital Management LLC
2.8M sh · $70.47M
Dimensional Fund Advisors LP
2.2M sh · $55.75M
Renaissance Technologies LLC
2.1M sh · $55.1M
State Street Corp
2.1M sh · $52.26M
D. E. Shaw & Co., Inc.
2.0M sh · $52.79M
Blackrock Fund Advisors
1.9M sh · $62.07M
Balyasny Asset Management L.P.
1.9M sh · $48.58M
Goldman Sachs Group Inc
1.6M sh · $35.48M
Morgan Stanley
1.4M sh · $31.47M

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity3
Return On Assets3
Debt To Equity2
Price To Earnings1
Price To Book3
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Tom Malinowski
Tom Malinowski
Purchase
2021-05-06

INSIDER TRADES

★
OFFICER: CHIEF MEDICAL OFFICER
SLONIN JONATHAN
Sale · 3.0K shares
2026-08-17
★
DIRECTOR:
WIGGANS THOMAS G
— · —
2026-06-09
★
DIRECTOR
YANG MICHAEL J.
Purchase · 6.4K shares
2026-06-10
★
DIRECTOR
YANG MICHAEL J.
Purchase · 10.9K shares
2026-06-10

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
SECTOR PERFORM 1
EQUAL WEIGHT 1
5 GRADES IN THE LAST 12 MONTHS
Needham BUY RBC Capital SECTOR PERFORM HC Wainwright & Co. BUY Barclays EQUAL WEIGHT Truist Securities BUY

SECTORS PEERS

PEERPRICE
KOD$35.63COMPARE
URGN$43.84COMPARE
XNCR$26.61COMPARE
ANAB$56.51COMPARE
TNDM$20.30COMPARE
CRON$3.24COMPARE
PHAT$9.26COMPARE
BBOT$9.04COMPARE